Fruit-derived flavonoids and carotenoids in cardiovascular prevention: mechanisms and clinical evidence
Romanian Journal of Pharmaceutical Practice · 30.06.2026 · 19 (1-2) · 45
DOI: 10.37897/rjphp.2026.1-2.5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Romanian Journal of Pharmaceutical Practice, online erschienen am 24.05.2026. Verfasst von Azan Hassan und 4 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Fruit-derived flavonoids and carotenoids have attracted interest because of their potential effects on vascular function, inflammation, oxidative processes, and lipid metabolism. However, evidence from whole-fruit consumption, circulating phytochemical concentrations, and isolated supplementation is not interchangeable.
Objective
To critically examine the mechanisms and clinical evidence linking fruit-derived flavonoids and carotenoids with cardiovascular prevention.
Methods
This narrative review critically examines selected food-composition studies, experimental investigations, prospective observational studies, randomized trials, and evidence syntheses. Particular attention is given to preparation, exposure, study population, outcome selection, and the distinction between cardiovascular risk markers and clinical events.
Results
Observational studies link some measures of flavonoid intake and carotenoid status with favorable cardiovascular outcomes, but associations differ among compounds and populations. Randomized trials report improvements in selected vascular measurements after some berry, citrus, apple, and tomato interventions, whereas other studies show no significant effects. Evidence syntheses suggest more consistent anthocyanin-related effects on endothelial function than on blood pressure or lipid concentrations. Food composition, processing, metabolism, and intestinal microbial activity may contribute to variable responses. Long-term beta-carotene supplementation has not reproduced the benefits anticipated from dietary associations, and a combined beta-carotene-vitamin A intervention raised important safety concerns.
Conclusions
Selected fruit-derived preparations may influence vascular function and other intermediate outcomes, but current evidence does not establish uniform cardiovascular protection attributable specifically to flavonoids or carotenoids. Whole foods, processed products, and isolated supplements should be evaluated separately. Better-characterized, longer-term interventions with clinically meaningful outcomes are needed.
Zitieren
APA
Hassan, A., Murad, S., Saifuddin, S., Fatima, A., & Awan, P. (2026). Fruit-derived flavonoids and carotenoids in cardiovascular prevention: mechanisms and clinical evidence. Romanian Journal of Pharmaceutical Practice, 19(1-2), 45. https://doi.org/10.37897/rjphp.2026.1-2.5
Vancouver
Hassan A, Murad S, Saifuddin S, Fatima A, Awan P. Fruit-derived flavonoids and carotenoids in cardiovascular prevention: mechanisms and clinical evidence. Romanian Journal of Pharmaceutical Practice. 2026;19(1-2):45. doi:10.37897/rjphp.2026.1-2.5
BibTeX
@article{Hassan2026,
author = {Hassan, Azan and Murad, Shah and Saifuddin, Seema and Fatima, Ajaz and Awan, Palwasha},
title = {Fruit-derived flavonoids and carotenoids in cardiovascular prevention: mechanisms and clinical evidence},
journal = {Romanian Journal of Pharmaceutical Practice},
year = {2026},
volume = {19},
number = {1-2},
pages = {45},
doi = {10.37897/rjphp.2026.1-2.5}
}
EUVIMED